ADVM - Adverum Biotechnologies Stock Trading

-- Based on latest analyses, company is revising ADVM-022 development plan to focus on wet AMD and low doses (2 x 10^11 vg/eye and lower); no longer planning development for DME -- -- Company to host conference call and webcast today at 1:30 pm PT / 4:30 pm ET -- RED...

Adverum Biotechnologies Inc. (NASDAQ:ADVM) traded today at a new 52-week low of $3.04. So far today approximately 271,000 shares have been exchanged, as compared to an average 30-day volume of 2.3 million shares. Adverum Biotechnologies Inc. has overhead space with shares priced $3.07, o...

Adverum Biotechnologies Inc. (NASDAQ:ADVM) traded today at a new 52-week low of $3.31. So far today approximately 271,000 shares have been exchanged, as compared to an average 30-day volume of 2.3 million shares. In the past 52 weeks, shares of Adverum Biotechnologies Inc. have traded be...